Skip to main content

Table 1 Basic patient demographics

From: Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma

 

Discovery stage

Validation stage

NPC

Control

NPC

Control

Number

7

7

129

100

Gender

 Male

5

5

100

41

 Female

2

2

29

59

Mean age ± SD (years)

59 ± 12

59 ± 10

51 ± 12

51 ± 10

Age range (years)

38–76

40–74

19–76

24–79

T stage

 T1

0

 

19

 

 T2

2

 

46

 

 T3

3

 

39

 

 T4

2

 

25

 

N stage

 N0

1

 

17

 

 N1

1

 

50

 

 N2

5

 

55

 

 N3

0

 

7

 

M stage

 M0

6

 

122

 

 M1

1

 

7

 

Overall stage

 I

0

 

4

 

 II

0

 

36

 

 III

4

 

55

 

 IV

3

 

34

Â